Hyperglycosylated HCG expression in pregnancy: Cellular origin and clinical applications

Molecular and Cellular Endocrinology

Volumn 260-262, Issue , 2007, Pages 237-243

  Kovalevskaya, G ^a   Kakuma, T ^b   Schlatterer, J ^a   O'Connor, J F ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Cytotrophoblast; Early pregnancy loss; Hyperglycosylated hCG; Placenta

Indexed keywords

CHORIONIC GONADOTROPIN; HYPERGLYCOSYLATED CHORIONIC GONADOTROPIN; PLACENTAL PEPTIDE HORMONE; UNCLASSIFIED DRUG;

CELL ASSAY; CYTOTROPHOBLAST; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DOWN SYNDROME; EARLY DIAGNOSIS; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HORMONE DETERMINATION; LABORATORY TEST; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PREGNANCY TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN VARIANT; REVIEW; SCREENING TEST; SPONTANEOUS ABORTION; SYNCYTIOTROPHOBLAST; THIRD TRIMESTER PREGNANCY; URINALYSIS;

ABORTION, SPONTANEOUS; CHORIOCARCINOMA; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; EMBRYO LOSS; FEMALE; FERTILIZATION IN VITRO; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; OLIGOSACCHARIDES; PREGNANCY; PREGNANCY TRIMESTERS; PROTEIN ISOFORMS; SENSITIVITY AND SPECIFICITY;

EID: 33751203568     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.02.021     Document Type: Review

References (41)

1. Amano J., Nishimura R., Mochizuki M., and Kobata A. Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women. J. Biol. Chem. 263 (1988) 1157-1165
2. Avgidou K., Papageorghiou A., Bindra R., Spencer K., and Nicolaides K.H. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am. J. Obstet. Gynecol. 192 (2005) 1761-1767
3. Bahado-Singh R.O., Oz U., Shahabi S., Mahoney M.J., Baumgarten A., and Cole L.A. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Am. J. Obstet. Gynecol. 183 (2000) 1114-1118
4. Birken S. Specific measurement of O-linked core 2 sugar-containing isoforms of hyperglycosylated human chorionic gonadotropin by antibody B152. Tumour Biol. 26 (2005) 131-141
5. Birken S., Krichevsky A., O'Connor J., Schlatterer J., Cole L., Kardana A., and Canfield R. Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocrine 10 (1999) 137-144
6. Birken S., Yershova O., Myers R.V., Bernard M.P., and Moyle W. Analysis of human choriogonadotropin core 2 O-glycan isoforms. Mol. Cell. Endocrinol. 204 (2003) 21-30
7. Butler S.A., Khanlian S.A., and Cole L.A. Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. Clin. Chem. 47 (2001) 2131-2136
8. Christiansen M., Larsen S.O., Oxvig C., Qin Q.P., Wagner J.M., Overgaard M.T., Gleich G.J., Sottrup-Jensen L., and Norgaard-Pedersen B. Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers. Clin. Genet. 65 (2004) 11-16
9. Cole L.A. The O-linked oligosaccharide structures are striking different on pregnancy and choriocarcinoma HCG. J. Clin. Endocrinol. Metab. 65 (1987) 811-813
10. Cole L.A., Khanlian S.A., Sutton J.M., Davies S., and Rayburn W.F. Accuracy of home pregnancy tests at the time of missed menses. Am. J. Obstet. Gynecol. 190 (2004) 100-105
11. Cole L.A., Khanlian S.A., Sutton J.M., Davies S., and Stephens N.D. Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin. Biochem. 36 (2003) 647-655
12. Cole L.A., Omrani A., Cermik D., Bahado-Singh R.O., and Mahoney M.J. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening. Prenat. Diagn. 18 (1998) 926-933
13. Cole L.A., Shahabi S., Oz U.A., Bahado-Singh R.O., and Mahoney M.J. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin. Chem. 45 (1999) 2109-2119
14. Cole L.A., Shahabi S., Oz U.A., Rinne K.M., Omrani A., Bahado-Singh R.O., and Mahoney M.J. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG. Prenat. Diagn. 19 (1999) 351-359
15. Cuckle H.S., Shahabi S., Sehmi I.K., Jones R., and Cole L.A. Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome. Prenat. Diagn. 19 (1999) 918-920
16. Diaz-Cueto L., Barrios-de-Tomasi J., Timossi C., Mendez J.P., and Ulloa-Aguirre A. More in vitro bioactive, shorter-lived human chorionic gonadotrophin charge isoforms increase at the end of the first and during the third trimesters of gestation. Mol. Hum. Reprod. 2 (1996) 643-650
17. Eiben B., and Glaubitz R. First-trimester screening: an overview. J. Histochem. Cytochem. 53 (2005) 281-283
18. Elliott M.M., Kardana A., Lustbader J.W., and Cole L.A. Carbohydrate and peptide structure of the alpha and beta subunits of chorionic gonadotropin (hCG): characteristics and variants in 32 subunit preparations from normal and aberrant pregnancy and choriocarcinoma. Endocrine 7 (1997) 15-32
19. Ellish N.J., Saboda K., O'Connor J., Nasca P.C., Stanek E.J., and Boyle C. A prospective study of early pregnancy loss. Hum. Reprod. 11 (1996) 406-412
20. Hallahan T., Krantz D., Orlandi F., Rossi C., Curcio P., Macri S., Larsen J., Buchanan P., and Macri J. First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG. Prenat. Diagn. 20 (2000) 785-789
21. Knight G.J., Palomaki G.E., Neveux L.M., Fodor K.K., and Haddow J.E. hCG and the free beta-subunit as screening tests for Down syndrome. Prenat. Diagn. 18 (1998) 235-245
22. Kobata A., and Takeuchi M. Structure, pathology and function of the N-linked sugar chains of human chorionic gonadotropin. Biochim. Biophys. Acta 1455 (1999) 315-326
23. Kovalevskaya G., Birken S., Kakuma T., and O'Connor J.F. Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. J. Endocrinol. 161 (1999) 99-106
24. Kovalevskaya G., Birken S., Kakuma T., Ozaki N., Sauer M., Lindheim S., Cohen M., Kelly A., Schlatterer J., and O'Connor J.F. Differential expression of hCG glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J. Endocrinol. 172 (2002) 497-506
25. Kovalevskaya G., Genbacev O., Fisher S.J., Caceres E., and O'Connor J.F. Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG. Mol. Cell. Endocrinol. 194 (2002) 147-155
26. Laird N.M., and Ware J.H. Random-effects models for longitudinal data. Biometrics 38 (1982) 963-974
27. Malone F.D., Canick J.A., Ball R.H., Nyberg D.A., Comstock C.H., Bukowski R., Berkowitz R.L., Gross S.J., Dugoff L., Craigo S.D., Timor-Tritsch I.E., Carr S.R., Wolfe H.M., Dukes K., Bianchi D.W., Rudnicka A.R., Hackshaw A.K., Lambert-Messerlian G., Wald N.J., and D'Alton M.E. First-trimester or second-trimester screening, or both, for Down's syndrome. N. Engl. J. Med. 353 (2005) 2001-2011
28. Nemansky M., Thotakura N.R., Lyons C.D., Ye S., Reinhold B.B., Reinhold V.N., and Blithe D.L. Developmental changes in the glycosylation of glycoprotein hormone free alpha subunit during pregnancy. J. Biol. Chem. 273 (1998) 12068-12076
29. Nicolaides K.H., Spencer K., Avgidou K., Faiola S., and Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet. Gynecol. 25 (2005) 221-226
30. Nishimura R., Ide K., Utsunomiya T., Kitajima T., Yuki Y., and Mochizuki M. Fragmentation of the beta-subunit of human chorionic gonadotropin produced by choriocarcinoma. Endocrinology 123 (1988) 420-425
31. O'Connor J.F., Ellish N., Kakuma T., Schlatterer J., and Kovalevskaya G. Differential urinary gonadotropin profiles in early pregnancy and early pregnancy loss. Prenat. Diagn. 18 (1998) 1232-1240
32. O'Connor J.F., Birken S., Lustbader J.W., Krichevsky A., Chen Y., and Canfield R.E. Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. Endocr. Rev. 15 (1994) 650-683 (Review; 207 refs.)
33. Palomaki G.E., Knight G.J., Neveux L.M., Pandian R., and Haddow J.E. Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening. Clin. Chem. 51 (2005) 1499-1504
34. Palomaki G.E., Neveux L.M., Knight G.J., Haddow J.E., and Pandian R. Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester. Clin. Chem. 50 (2004) 1804-1808
35. Pandian R., Cole L.A., and Palomaki G.E. Second-trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening. Clin. Chem. 50 (2004) 1433-1435
36. Skarulis M.C., Wehmann R.E., Nisula B.C., and Blithe D.L. Glycosylation changes in human chorionic gonadotropin and free alpha subunit as gestation progresses. J. Clin. Endocrinol. Metab. 75 (1992) 91-96
37. Spencer K., Berry E., Crossley J.A., Aitken D.A., and Nicolaides K.H. Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?. Prenat. Diagn. 20 (2000) 311-317
38. Weinans M.J., Butler S.A., Mantingh A., and Cole L.A. Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities. Prenat. Diagn. 20 (2000) 976-978
39. Weinans M.J., Sancken U., Pandian R., van de Ouweland J.M., de Bruijn H.W., Holm J.P., and Mantingh A. Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) as a first-trimester serum marker for Down syndrome. Clin. Chem. 51 (2005) 1276-1279
40. Wide L., and Hobson B. Some qualitative differences of hCG in serum from early and late pregnancies and trophoblastic diseases. Acta Endocrinol. (Copenh.) 116 (1987) 465-472
41. Wide L., Lee J.Y., and Rasmussen C. A change in the isoforms of human chorionic gonadotropin occurs around the 13th week of gestation. J. Clin. Endocrinol. Metab. 78 (1994) 1419-1423